Redhill Biopharma Stock Forum

$Redhill Biopharma (RDHL.US)$
RedHill Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041
New U.S. patent issued covering the identification of a novel biomarker of coronavirus pneumonia (≤60% fraction of inspired oxygen (FiO2)) prognostic for potential opaganib efficacy in treating COVID-19, valid through 204
Published post-hoc data from opaganib's Phase2/3 study showed that patients with ≤60% FiO2 levels had better outcomes after 14 days' opaganib treatment (n=117) comp...

$Indonesia Energy (INDO.US)$👈 buy the blood ignore the FUD 😑🤜💥🐻 $Faraday Future Intelligent Electric Inc. (FFIE.US)$ $Redhill Biopharma (RDHL.US)$

$Redhill Biopharma (RDHL.US)$
RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines

$Redhill Biopharma (RDHL.US)$ Redhill Biopharma Announced The Publication Of Data, In Journal Microorganisms, From The Phase 2/3 Study Of Opaganib In Covid-19 Pneumonia That Showed 62% Reduction In Covid-19 Mortality
Benzinga· 2 mins ago

$Emergent BioSolutions (EBS.US)$ 👀could it be .... possible comeback? EBS is one of three companies ready to deploy mpox vaccines. With that said, you look at institutions owning this and you have the two largest with BlackRock and Vanguard..... plus Charles Schwab is no tiny outfit. $Iovance Biotherapeutics (IOVA.US)$ $Redhill Biopharma (RDHL.US)$

$Redhill Biopharma (RDHL.US)$
RedHill's Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma
RedHill Biopharma (Nasdaq: RDHL) has announced that the FDA has granted orphan-drug designation to opaganib for the treatment of neuroblastoma, a rare childhood cancer.
This designation provides seven years of marketing exclusivity if approved and may offer additional benefits such as accelerated development and review times, potential grant funding, and tax credits...